Compagnie Lombard Odier SCmA’s AbbVie ABBV Stock Holding History

Compagnie Lombard Odier SCmA’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-7,300	Closed	-$94K	–	497
2019 Q4	$94K	Hold	7,300	–	–	﹤0.01%	322
2019 Q3	$28K	Hold	7,300	–	–	﹤0.01%	401
2019 Q2	$27K	Buy	+7,300	New	+$574K	﹤0.01%	405
2019 Q1	–	Sell	-1,200	Closed	-$1K	–	572
2018 Q4	$1K	Hold	1,200	–	–	﹤0.01%	537
2018 Q3	$6K	Buy	+1,200	New	+$114K	﹤0.01%	528
2018 Q2	–	Sell	-10,000	Closed	-$4K	–	595
2018 Q1	$4K	Buy	+10,000	New	+$1.1M	﹤0.01%	582
2017 Q2	–	Sell	-3,200	Closed	-$3K	–	704
2017 Q1	$3K	Buy	+3,200	New	+$201K	﹤0.01%	700

Other funds holding ABBV

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Compagnie Lombard Odier SCmA's ABBV Position: Q2 2026 in Review

Compagnie Lombard Odier SCmA reduced its AbbVie (ABBV) stake by 11% in Q2 2026, selling an estimated $7.16M and leaving 276,074 shares worth $69.5M. The position accounts for 0.75% of the portfolio, ranked #29.

Compagnie Lombard Odier SCmA first reported a position in ABBV in Q4 2013 and has held it in 51 quarters since. The position peaked at $285M in Q4 2017. 2,625 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Compagnie Lombard Odier SCmA held 276,074 shares of AbbVie worth $69.5M as of Q2 2026.
Compagnie Lombard Odier SCmA sold 33,277 AbbVie shares in Q2 2026, an estimated $7.16M.
AbbVie made up 0.75% of Compagnie Lombard Odier SCmA's portfolio in Q2 2026, its #29 holding.
Compagnie Lombard Odier SCmA first reported a position in AbbVie in Q4 2013 and has held it in 51 quarters since.
Compagnie Lombard Odier SCmA's AbbVie position peaked at $285M in Q4 2017.
2,625 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Compagnie Lombard Odier SCmA's 13F filing for Q2 2026, filed 29 Jul 2026.